ObamaCare Is All About Rationing: Difference between revisions
Jump to navigation
Jump to search
Yaron Koren (talk | contribs) No edit summary |
Yaron Koren (talk | contribs) m (Text replace - 'America's Affordable Health Choices Act of 2009' to 'Patient Protection and Affordable Care Act') |
||
Line 6: | Line 6: | ||
|quote="In the British national health service, a government agency approves only those expensive treatments that add at least one Quality Adjusted Life Year (QALY) per £30,000 (about $49,685) of additional health-care spending. If a treatment costs more per QALY, the health service will not pay for it. The existence of such a program in the United States would not only deny lifesaving care but would also cast a pall over medical researchers who would fear that government experts might reject their discoveries as "too expensive." | |quote="In the British national health service, a government agency approves only those expensive treatments that add at least one Quality Adjusted Life Year (QALY) per £30,000 (about $49,685) of additional health-care spending. If a treatment costs more per QALY, the health service will not pay for it. The existence of such a program in the United States would not only deny lifesaving care but would also cast a pall over medical researchers who would fear that government experts might reject their discoveries as "too expensive." | ||
}} | }} | ||
{{Opinion| | {{Opinion|Patient Protection and Affordable Care Act|Act should be passed|against}} |
Latest revision as of 14:37, March 11, 2010
This is an opinion item.
Author(s) | Martin Feldstein |
---|---|
Source | The Wall Street Journal |
Date | August 18, 2009 |
URL | http://online.wsj.com/article/SB10001424052970204683204574358233780260914.html |
Quote |
Add or change this opinion item's references
This item argues against the position Act should be passed on the topic Patient Protection and Affordable Care Act.